Valuable data for health admin is dif than value for researcher, patient—need to solve the problem from perspective of who needs it #PMConf

Eck: Future world w/ more uniform system that addresses needs of researchers, clinicians, admins. Long way to go but needed #PMConf

Yeshwant: hard to address global connectivity but it’s energizing. Opportunity to go beyond US #PMConf @GoogleVentures Brigham and Women's Hospital

Daniel Skovronsky, VP Tailored Therapeutics Former Account of Eli Lilly and Company Former Account of Eli Lilly and Company presents keynote on #personalizedmedicine in industry #PMConf

Skovronsky: Former Account of Eli Lilly and Company targetedted trials in Alzheimer’s Disease. Next step to use targeting to enable prevention #PMConf Former Account of Eli Lilly and Company

Understanding disease pathology & targeting therapies is pillar for Former Account of Eli Lilly and Company Former Account of Eli Lilly and Company in speeding new treatments to patients #PMConf

David Sweetser MassGeneral News @PartnersNews opens session w/ panel on #personalizedmedicine & prenatal, childhood disorders #PMConf

Benjamin Solomon Inova Trnsltl Med Inst wrestles everyday w/ managing omic data, patient care & “first do no harm” #PMConf

Holmes Morton, Medical Director @ClinicSpecChild “ultimately healthcare is a local service.” #PMConf

Solomon Inova important to guide patients through understanding child’s genetic information & ramifications for parents. #PMConf

Morton: Nationwide newborn screening began w/ local screening in Amish community in PA & grew. Much to learn from small ppltns #PMConf

Solomon “Need for paternal blood draw is biggest reason ppl don’t participate in newborn genetic screening.” Wow! #PMConf

Diana Bianchi Tufts Medical Center: Measure of success is accuracy in prenatal testing & freedom of choice. Not disease elimination #PMConf

Education needed for PCPs to undrstnd & explain what genetic info reveals, what you can do says Sweester MassGeneral News #PMConf

Michael Kolodziej, Aetna: Payment decisions are based on obligations to healthcare ecosystem which is consumers & payers #PMConf

Kolodziej: Need collab w/ an evidence accumulating body to help identify value added by targeted therapies & companion Dx #PMConf

.Dr. Catalina Lopez-Correa (She/Her 🏳️‍🌈🇨🇦🇨🇴) draws parallel btw challenges in Canada & US re: disconnect in regulation & reimbursement or access decisions #PMConf

That's a wrap on the 10th Anniversary #PMConf - thanks for joining us! We'll see you back here Nov. 18-19, 2015!

1 week left to register for the 11th annual #PMConf. Follow PersonalizedMedicine Nov. 18-19 for live updates bit.ly/pmconfreg

If you're headed to the #PMConf tomorrow, follow PersonalizedMedicine for live updates. Hope to see you there! bit.ly/pmconfagenda